Biotechpharma UAB appoints Frank Ternes as Chief Business Officer

01 October

Biotechpharma UAB, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, is pleased to announce the appointment of Frank Ternes as Chief Business Officer effective from 1 October 2018. Frank will manage all sales, marketing and business development functions and will report directly to CEO, Dr. Vladas Algirdas Bumelis.

Frank is a passionate leader who has a vast amount of experience within the life sciences industry. During his 30-year career, he has held a variety of senior roles, most recently including Chief Business Officer of Rentschler Biotechnologie and Sr VP Contract Manufacturing Business of Boehringer Ingelheim.

Dr Bumelis, CEO of Biotechpharma said:

“I am delighted that Frank will be joining our team at this exciting time for the company, and I look forward to working with him as we strive to ensure continuous growth of the company, expand our footprint in the US market and improve the experience of our customers. Frank brings with him a wealth of experience spanning operations, sales, business development and management and he will help to achieve ambitious goal of Biotechpharma to become a Top 10 player in large molecule CDMO industry.”

Frank Ternes commented:

“I am looking forward to be joining Biotechpharma, a fast growing player in biologics CDMO market that has an exciting vision and international growth strategy. It is an exciting proposition to work with the team to grow Biotechpharma’s customers base worldwide and drive the implementation of its business expansion plan.”

back to list